Beyond the Lab: Making Precision Genomics an Enterprise Asset

This webinar brings health system executives and precision medicine leaders together to examine a pivotal shift: from episodic testing to enterprise-wide capability. Featuring perspectives from Natera — a national leader in cell-free DNA diagnostics — the session addresses what it takes to operationalize precision genomics at scale across a health system. The program moves through three strategic pillars: the clinical and population health impact of genomic testing, the EHR integration and workflow standardization required to deploy it at scale, and the data partnership infrastructure needed to turn fragmented molecular data into actionable intelligence. Designed specifically for C-suite and D-suite health system leaders, this webinar provides both the strategic case and the operational roadmap for making precision genomics a sustainable enterprise capability. Objectives • Evaluate the impact of precision genomics on clinical outcomes and operational performance. • Explore strategies to standardize genomic testing workflows across service lines, care settings, and provider groups. • Understand how health systems can leverage real-world evidence and genomic data to advance research, quality, and patient outcomes. Key Takeaways: 1. Precision medicine is becoming an enterprise capability — moving beyond individual tests to longitudinal patient management that advances outcomes while reducing overtreatment. 2. Workflow integration is essential for scale — EHR integration reduces friction and provider burden; standardized pathways drive consistency and system-wide adoption. 3. Data must become actionable — linking molecular, clinical, and outcomes data into a unified, analytics-ready platform is foundational for quality improvement, research, and AI initiatives. 4. Success requires partnership — technology alone is not sufficient; precision genomics delivers the greatest value when embedded into routine care through a committed, long-term partnership model.